Martin Dekker

Companies

• Bellerophon Therapeutics (United States)VP of Device Engineering May 22, 2015 to Jun 9, 2023¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• BTBellerophon Therapeutics (United States)17,666 shares²Dec 9, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Dec 9, 2022Shares withheld for tax 7,834 shares at $0.93 of Bellerophon Therapeutics (United States)²
• Dec 9, 2022Exercised options 25,500 shares of Bellerophon Therapeutics (United States)²